{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:25:08Z","timestamp":1791174308500,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["IAP P7\/30"],"award-info":[{"award-number":["IAP P7\/30"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1841713N"],"award-info":[{"award-number":["1841713N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["BOF14\/GOA\/019"],"award-info":[{"award-number":["BOF14\/GOA\/019"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["260895"],"award-info":[{"award-number":["260895"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009946","name":"Allergopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128241"],"award-info":[{"award-number":["R01HL128241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI095219"],"award-info":[{"award-number":["U19AI095219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaip.2020.11.017","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T16:59:31Z","timestamp":1605891571000},"page":"1099-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps"],"prefix":"10.1016","volume":"9","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Y.","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 1","key":"10.1016\/j.jaip.2020.11.017_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib2","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.158.8.3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"158","author":"Simon","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0091-6749(03)70044-X","article-title":"IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma","volume":"111","author":"Bachert","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2500\/ajra.2014.28.4033","article-title":"Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps","volume":"28","author":"Van Zele","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2011.11.007","article-title":"IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis","volume":"11","author":"Derycke","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2020.11.017_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2500\/ajra.2013.27.3922","article-title":"Inflammatory patterns in upper airway disease in the same geographical area may change over time","volume":"27","author":"Katotomichelakis","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2019.06.023","article-title":"Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps","volume":"144","author":"Wang","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaci.2019.08.027","article-title":"Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis","volume":"145","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaci.2016.03.045","article-title":"Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus","volume":"139","author":"Stentzel","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2017.05.004","article-title":"The IL-33\/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D","volume":"141","author":"Teufelberger","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jprot.2017.12.003","article-title":"Staphylococcus aureus controls interleukin-5 release in upper airway inflammation","volume":"180","author":"Bachert","year":"2018","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.jaip.2020.11.017_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.molmed.2019.05.003","article-title":"Staphylococcus aureus orchestrates type 2 airway diseases","volume":"25","author":"Teufelberger","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaip.2020.11.017_bib18","doi-asserted-by":"crossref","first-page":"1901592","DOI":"10.1183\/13993003.01592-2019","article-title":"Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge","volume":"55","author":"Bachert","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.11.017_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","article-title":"Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines","volume":"198","author":"Lan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.11.017_bib20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","article-title":"Endotype-driven care pathways in patients with chronic rhinosinusitis","volume":"141","author":"Bachert","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2020.01.019","article-title":"Endotypes of chronic rhinosinusitis: impact on management","volume":"145","author":"Cardell","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/lary.27815","article-title":"Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study","volume":"129","author":"Alsharif","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.11.017_bib24","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"Suppl. S29","key":"10.1016\/j.jaip.2020.11.017_bib25","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.11.017_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2500\/ajra.2014.28.4054","article-title":"Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease","volume":"28","author":"Johns","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic\u00a0sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2020.11.017_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3758\/BF03210709","article-title":"Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test","volume":"45","author":"Doty","year":"1989","journal-title":"Percept Psychophys"},{"key":"10.1016\/j.jaip.2020.11.017_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2020.11.017_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jaip.2020.11.017_bib33","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.jaip.2019.03.023","article-title":"Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.11.017_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib38","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","article-title":"IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy","volume":"7","author":"Humbert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib39","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaip.2020.02.023","article-title":"Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics: a National Institute of Allergy and Infectious Diseases Workshop","volume":"8","author":"Naclerio","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2020.01.020","article-title":"Biologics for chronic rhinosinusitis with nasal polyps","volume":"145","author":"Bachert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.11.017_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"van der Veen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/all.12040","article-title":"Uncontrolled allergic rhinitis and chronic rhinosinusitis: Where do we stand today?","volume":"68","author":"Hellings","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib43","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s00405-014-3456-x","article-title":"Endoglin (CD105) expression in sinonasal polyposis","volume":"272","author":"Ottaviano","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.11.017_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13601-019-0269-4","article-title":"Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis","volume":"9","author":"Calus","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib45","author":"Jonstam"},{"key":"10.1016\/j.jaip.2020.11.017_bib46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaip.2016.09.015","article-title":"Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis","volume":"5","author":"Phillips","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/antibiotics8040175","article-title":"Exacerbations of chronic rhinosinusitis-microbiology and perspectives of phage therapy","volume":"8","author":"Szaleniec","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jaip.2020.11.017_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.11.017_bib49","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00405-013-2467-3","article-title":"Impact of fungal load on diagnosis and outcome of allergic fungal rhinosinusitis","volume":"271","author":"Ragab","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.11.017_bib51","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00405-013-2449-5","article-title":"The prevalence of allergic fungal rhinosinusitis in sinonasal polyposis","volume":"270","author":"Bakhshaee","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.11.017_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaip.2016.03.010","article-title":"Allergic fungal rhinosinusitis","volume":"4","author":"Hoyt","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.11.017_bib53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005537-199904000-00005","article-title":"Surgical experience and complications during endonasal sinus surgery","volume":"109","author":"Keerl","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.11.017_bib54","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/all.14408","article-title":"Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA","volume":"75","author":"Seys","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.11.017_bib55","first-page":"384","article-title":"Rhinology future debates 2018, a EUFOREA report","volume":"58","author":"Prokopakis","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.11.017_bib56","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jaip.2020.03.001","article-title":"The rationale for multidisciplinary management of chronic rhinosinusitis with nasal polyposis","volume":"8","author":"Lal","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982031237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982031237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:27:23Z","timestamp":1761974843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982031237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S221321982031237X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.11.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}